WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 206205
Description: Sulfatinib, also known as surufatinib, is an orally bioavailable, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, and the fibroblast growth factor receptor type 1 (FGFR1), with potential antineoplastic and anti-angiogenic activities. Upon oral administration, sulfatinib binds to and inhibits VEGFRs and FGFR1 thereby inhibiting VEGFR- and FGFR1-mediated signal transduction pathways. This leads to a reduction of angiogenesis and tumor cell proliferation in VEGFR/FGFR1-overexpressing tumor cells. Expression of VEGFRs and FGFR1 may be upregulated in a variety of tumor cell types.
MedKoo Cat#: 206205
Chemical Formula: C24H28N6O3S
Exact Mass: 480.1944
Molecular Weight: 480.587
Elemental Analysis: C, 59.98; H, 5.87; N, 17.49; O, 9.99; S, 6.67
Related CAS #: 1308672-74-3 1816307-67-1.
Synonym: HMPL012; HMPL012; HMPL 012; Sulfatinib; surufatinib;
IUPAC/Chemical Name: N-(2-(dimethylamino)ethyl)-1-(3-((4-((2-methyl-1H-indol-5-yl)oxy)pyrimidin-2-yl)amino)phenyl)methanesulfonamide
InChi Key: TTZSNFLLYPYKIL-UHFFFAOYSA-N
InChi Code: InChI=1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29)
SMILES Code: CC1=CC2=C(N1)C=CC(OC3=NC(NC4=CC(CS(NCCN(C)C)(=O)=O)=CC=C4)=NC=C3)=C2